(c) 2024 PillSync.com

Vitafol OB (vitamin a 2700 [iu] ascorbic acid 70 mg vitamin d 400 [iu] .alpha.-tocopherol 30 [iu] thiamine mononitrate 1.6 mg riboflavin 1.8 mg niacin 18 mg pyridoxine hydrochloride 2.5 mg folic acid 1 mg cyanocobalamin 12 ug calcium 100 mg iron 65 mg magnesium 25 mg zinc 25 mg copper 2 mg) Dailymed



IMPRINT: EV0079     SHAPE: oval
    COLOR: blue

Boxed Warning

Warning

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.


Go PRO for all pill images

Rx Only


Composition


Each Caplet contains:
VITAMINS AND MINERALS:
Vitamin A (as beta carotene) 810
mcg RAE
Vitamin C (as ascorbic acid) 70 mg
Vitamin D (as cholecalciferol) 10 mcg

Vitamin E

(as dl-alpha tocopheryl acetate)
13.5 mg

Thiamin

(Vitamin B1 as thiamine mononitrate)
1.6 mg
Riboflavin (Vitamin B2) 1.8 mg
Niacin (as niacinamide) 18 mg NE
Vitamin B6 (as pyridoxine hydrochloride) 2.5 mg
Folate (as folic acid) 1700 mg DFE
Vitamin B12 (as cyanocobalamin) 12 mcg
Calcium (as calcium carbonate) 100 mg
Iron (as ferrous fumarate) 65 mg
Magnesium (as magnesium oxide) 25 mg
Zinc (as zinc oxide) 25 mg
Copper (as copper oxide) 2 mg

Other Ingredients: microcrystalline cellulose, croscarmellose sodium, silicon dioxide, maltodextrin, copovidone, stearic acid, hydroxypropyl methylcellulose, dicalcium phosphate, acacia gum, titanium dioxide, polydextrose, starch, magnesium stearate, triacetin, modified food starch, mannitol, vitamin E alcohol, polyethylene glycol, talc, FD&C Blue #1, FD&C Blue #2.

Indications And Usage


Vitafol ®-OB is indicated to provide vitamin, mineral, supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.*

Contraindications


Vitafol ®-OB is contraindicated in patients with hypersensitivity to any of its components or color additives.

Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.

Iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver.

Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin B-12).

Warning


Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.

Warnings/precautions


Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur.

Prolonged use of iron salts may produce iron storage disease.

Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive.

The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency.

Avoid Overdosage. Keep out of the reach of children.

Precautions Section


DRUG INTERACTIONS


High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs.

Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.

Zinc can inhibit the absorption of certain antibiotics; take at least 2 hours apart to minimize interactions.

Consult appropriate references for additional specific vitamin-drug interactions.

Information for Patients


Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breast-feeding.

Pediatric Use


Not for pediatric use.

Adverse Reactions


Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Vitafol ®-OB. Allergic reactions have been reported with some forms of gum acacia to include respiratory problems and skin lesions.

Dosage And Administration


Before, during and after pregnancy, one caplet daily, or as directed by a physician.

How Supplied


Vitafol ®-OB is available as a light blue caplet, debossed EV0079. Available in Box of Unit-Dose pack of 100 (NDC 0642-0079-12) and as professional samples (0642-0079-03).

STORAGE AND HANDLING SECTION


Store at room temperature, approximately 15°-30°C (59°-86°F), avoid excessive heat and moisture.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Rx

Disributed by: Exeltis USA, Inc. Florham Park, NJ 07932 1-877-324-9349 www.exeltisusa.com ©2022 All rights reserved. Exeltis USA, Inc.

U.S. PATENT NO. 6,814,983; 7,390,509

Vitafol ® is a trademark of Exeltis Healthcare S.L.

Rev. December 2022 0791201-02

Principal Display Panel - 100 Caplet Carton


0642-0079-12

Vitafol ®-OB Prenatal Supplement

10 X 10 UNIT DOSE PACK 100 CAPLETS

R x



DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site